We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

47 hedge funds and large institutions have $77.5M invested in Redhill Biopharma in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

66% more capital invested

Capital invested by funds: $46.6M → $77.5M (+$31M)

15% more funds holding

Funds holding: 41 → 47 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

1% less call options, than puts

Call options by funds: $2.6M | Put options by funds: $2.63M

Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
20
Reduced
7
Closed
6
Calls
$2.6M
Puts
$2.63M
Net Calls
-$35K
Net Calls Change
-$311K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$1.12M
2
SC
Sculptor Capital
New York
+$894K
3
State Street
State Street
Massachusetts
+$738K
4
Goldman Sachs
Goldman Sachs
New York
+$582K
5
AIP
ARS Investment Partners
New York
+$484K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$344K
2
AIM
ARK Investment Management
Florida
-$189K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$180K
4
Simplex Trading
Simplex Trading
Illinois
-$156K
5
DGI
Disciplined Growth Investors
Minnesota
-$57.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$213K +$8.2K +1 +5%
ISL
27
Ingalls & Snyder LLC
New York
$202K -$8.2K -1 -5%
DADC
28
D.A. Davidson & Co
Montana
$197K +$16.4K +2 +12%
Morgan Stanley
29
Morgan Stanley
New York
$197K +$131K +16 +533%
RJA
30
Raymond James & Associates
Florida
$189K +$156K +19 New
Group One Trading
31
Group One Trading
Illinois
$183K -$344K -42 -70%
VF
32
Virtu Financial
New York
$181K +$148K +18 New
HF
33
HRT Financial
New York
$148K +$115K +14 New
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
$107K +$90.2K +11 New
Bank of America
35
Bank of America
North Carolina
$96K +$32.8K +4 +80%
VanEck Associates
36
VanEck Associates
New York
$84K – – –
CIBC Private Wealth Group
37
CIBC Private Wealth Group
Georgia
$80K +$98.4K +12 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$68K +$16.4K +2 +40%
UBS Group
39
UBS Group
Switzerland
$55K +$24.6K +3 +150%
Osaic Holdings
40
Osaic Holdings
Arizona
$37K +$16.4K +2 +100%
PAM
41
Panagora Asset Management
Massachusetts
$21K +$16.4K +2 New
CG
42
Cutler Group
California
$16K – – –
BWA
43
BDO Wealth Advisors
Florida
$10K +$8.2K +1 New
Citigroup
44
Citigroup
New York
$8K – – –
CP
45
Corbenic Partners
Pennsylvania
$5K – – –
SIS
46
Sound Income Strategies
Florida
$5K +$8.2K +1 New
CCM
47
Covington Capital Management
California
$3K – – –
IA
48
IFP Advisors
Florida
$3K – – –
PA
49
Parallel Advisors
California
$2K – – –
BHWM
50
Bay Harbor Wealth Management
Maryland
$1K – – –
1
2
3

RDHL Hedge Fund Activity: Q3 2020 in Review

47 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2020, worth a combined $77.5M — up 66% from $46.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new RDHL positions and 6 closed out — a net gain of 6 holders — while 20 added to existing stakes and 7 trimmed.

The largest buyer was Wells Fargo, adding an estimated $1.12M. The largest seller was Group One Trading, cutting an estimated $344K.

  • 47 institutional investors held Redhill Biopharma (RDHL) as of Q3 2020, up from 41 in Q2 2020.
  • Funds reported $77.5M of Redhill Biopharma stock for Q3 2020, up 66% quarter-over-quarter.
  • 12 funds opened new Redhill Biopharma positions in Q3 2020 and 6 closed out, a net change of +6 holders.
  • The largest Redhill Biopharma buyer in Q3 2020 was Wells Fargo, an estimated $1.12M added.
  • The largest Redhill Biopharma seller in Q3 2020 was Group One Trading, an estimated $344K sold.

Based on aggregated 13F filings for Q3 2020.